Covid Vaccine Studies
Below are more than 450 studies published reporting adverse events following Covid vaccination. Use ctrl+F to search by keywords.
| # | Title of Study | Link to Study | Keywords | Critical Findings |
|---|---|---|---|---|
| 1 | SARS-CoV-2 vaccination and uveitis: Are they linked? | Link | covid-19, vaccination, vaccine, autoimmune, inflammation | Uveitis is a serious ocular inflammatory condition. Vaccine-associated uveitis, while rare, has been repeatedly documented across multiple vaccine platforms, including hepatitis B and MMR. |
| 2 | A case of hyperacute postvaccinal encephalopathy after BNT162b2 nCoV-19 vaccine | Link | covid-19, vaccination, vaccine, encephalitis, complications | Seizure onset and progressive encephalopathy occurred within hours after the second dose. Imaging revealed meningeal enhancement; CSF showed mild pleocytosis—pointing to vaccine-associated neuroinflammation. |
| 3 | Acute messenger RNA-based SARS-CoV-2 vaccine–related meningitis/encephalitis is not uncommon | Link | covid-19, vaccination, vaccine, encephalitis, adverse | |
| 4 | Autoimmune/inflammatory syndrome induced by adjuvants | Link | autoimmune, inflammation, syndrome, vaccination | |
| 5 | Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): past, present, and | Link | autoimmune, inflammation, syndrome, vaccination | |
| 6 | Vaccines and Autoimmunity-From Side Effects to ASIA Syndrome. | Link | autoimmune, vaccine, syndrome | |
| 7 | Vaccines, adjuvants and autoimmunity. | Link | autoimmune, vaccine | |
| 8 | Association of post-vaccination adverse reactions after influenza vaccine with | Link | postvaccination, adverse, vaccine | |
| 9 | Factors influencing adverse events following COVID-19 vaccination. | Link | covid-19, vaccination, adverse | |
| 10 | Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on | Link | vaccine | |
| 11 | Examples of Outcome Reporting Bias in Vaccine Studies: Illustrating How | Link | ||
| 12 | A Case of Giant Cell Arteritis Presenting After COVID-19 Vaccination: Is It Just | Link | ||
| 13 | A Case of Giant Cell Arteritis With a Normal Erythrocyte Sedimentation Rate (ESR) | Link | ||
| 14 | Giant Cell Arteritis after COVID-19 Vaccination with Long-Term Follow-Up: A Case | Link | ||
| 15 | Giant Cell Arteritis Following COVID-19 Vaccination: A Case Report | Link | ||
| 16 | SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. | Link | ||
| 17 | Insights into new-onset autoimmune diseases after COVID-19 vaccination. | Link | ||
| 18 | Reactive arthritis after vaccination against SARS-CoV-2: A case series and a | Link | ||
| 19 | Reactive arthritis after COVID-19 vaccination. | Link | ||
| 20 | Corona Virus Disease-19 Vaccine-associated Autoimmune Disorders. | Link | ||
| 21 | [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in | Link | ||
| 22 | COVID-19 Vaccine Clinical Trials: A Bird's Eye Perspective. | Link | ||
| 23 | Type 1 diabetes mellitus following COVID-19 vaccination: a report of two cases | Link | ||
| 24 | New-onset autoimmune phenomena post-COVID-19 vaccination. | Link | ||
| 25 | New-onset IgA nephropathy following COVID-19 vaccination. | Link | ||
| 26 | COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the | Link | ||
| 27 | A Case of Combination of IgA Nephropathy and Interstitial Nephritis After | Link | ||
| 28 | Gross hematuria can be an impact of severe acute respiratory syndrome coronavirus | Link | ||
| 29 | New-Onset Acute Kidney Disease Post COVID-19 Vaccination. | Link | ||
| 30 | ANCA Associated Glomerulonephritis Following SARS-CoV-2 Vaccination: A Case | Link | ||
| 31 | Acute kidney disease following COVID-19 vaccination: a single-center | Link | ||
| 32 | De Novo Vasculitis after COVID-19 Vaccination. | Link | ||
| 33 | Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 | Link | ||
| 34 | Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and | Link | ||
| 35 | Case Report: New-Onset Rheumatoid Arthritis Following COVID-19 Vaccination. | Link | ||
| 36 | De Novo ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis After COVID-19 | Link | ||
| 37 | Microscopic Polyangiitis Following mRNA COVID-19 Vaccination: A Case Report. | Link | ||
| 38 | Cardiac Tamponade as a Complication of Microscopic Polyangiitis: A Case | Link | ||
| 39 | A Systematic Review of Perinuclear Antineutrophil Cytoplasmic Antibody-Associated | Link | ||
| 40 | SARS-CoV-2 vaccination-induced cutaneous vasculitis: Report of two new cases and | Link | ||
| 41 | Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna | Link | ||
| 42 | Medium-vessel vasculitis following COVID-19 moderna (mRNA-1273) vaccination and | Link | ||
| 43 | A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 Vaccination. | Link | ||
| 44 | Dengue After COVID-19 Vaccination: Possible and Might be Missed | Link | ||
| 45 | Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS) | Link | ||
| 46 | COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia | Link | ||
| 47 | COVID-19 vaccines and thrombosis with thrombocytopenia syndrome. | Link | ||
| 48 | Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. | Link | ||
| 49 | Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 | Link | ||
| 50 | Autoantibodies to protein S may explain rare cases of coagulopathy following | Link | ||
| 51 | Perspectives on vaccine induced thrombotic thrombocytopenia. | Link | ||
| 52 | Cerebral venous sinus thrombosis after adenovirus-vectored COVID-19 vaccination: | Link | ||
| 53 | Cerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management | Link | ||
| 54 | Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a | Link | ||
| 55 | Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus | Link | ||
| 56 | A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals | Link | ||
| 57 | An overview and single-arm meta-analysis of immune-mediated adverse events | Link | ||
| 58 | Thrombotic and Thromboembolic Complications After Vaccination Against COVID-19: A | Link | ||
| 59 | Thromboembolism after COVID-19 Vaccination: A Systematic Review of Such Events in | Link | ||
| 60 | New Onset Autoimmune Diseases after the Sputnik Vaccine. | Link | ||
| 61 | Cardiovascular Sequelae of the COVID-19 Vaccines. | Link | ||
| 62 | Serious neurological adverse events following immunization against SARS-CoV-2: a | Link | ||
| 63 | Neurological Complications Following COVID-19 Vaccination. | Link | ||
| 64 | Neurological manifestations of immune origin after COVID-19 vaccination: | Link | ||
| 65 | COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports | Link | ||
| 66 | Neurologic Safety Monitoring of COVID-19 Vaccines: Lessons From the Past to | Link | ||
| 67 | NEUROLOGICAL MANIFESTATIONS ASSOCIATED WITH COVID-19 VACCINE. | Link | ||
| 68 | Disproportionality analysis of adverse neurological and psychiatric reactions | Link | ||
| 69 | The Number of Neurological Side Effects of SARS-CoV-2 Vaccinations is Increasing | Link | ||
| 70 | Neurological side effects after SARS-CoV-2 vaccinations require thorough and comprehensive investigations | Link | ||
| 71 | Benign Fasciculation Syndrome and Migraine Aura without Headache: Possible Rare | Link | ||
| 72 | Integrative Korean medicine for recurrent lumbar disc herniation after | Link | ||
| 73 | Benign fasciculation syndrome and migraine aura without headache as possible | Link | ||
| 74 | Headache onset after vaccination against SARS-CoV-2: a systematic literature | Link | ||
| 75 | Prolonged headache with vaccine- and dose-specific headache pattern associated | Link | ||
| 76 | MOG encephalomyelitis after vaccination against severe acute respiratory syndrome | Link | ||
| 77 | Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 | Link | ||
| 78 | Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: | Link | ||
| 79 | New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 | Link | ||
| 80 | Characteristics of Persistent Symptoms Manifested after SARS-CoV-2 Vaccination: | Link | ||
| 81 | Fatal neuromyelitis optica after COVID-19 vaccination | Link | ||
| 82 | Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration? | Link | ||
| 83 | COVID-19 mRNA vaccination leading to CNS inflammation: a case series | Link | ||
| 84 | Aquaporin-4 IgG neuromyelitis optica spectrum disorder onset after Covid-19 | Link | ||
| 85 | Neuromyelitis optica complicating COVID vaccinations | Link | ||
| 86 | Optic neuromyelitis after vaccination against SARS-CoV-2. | Link | ||
| 87 | Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse | Link | ||
| 88 | A Case Presenting with Neuromyelitis Optica Spectrum Disorder and Infectious | Link | ||
| 89 | Relapsing Anti-MOG Antibody-associated Disease following COVID-19 Vaccination: A | Link | ||
| 90 | FLAIR hyperintense cortical lesions in anti-myelin oligodendrocyte glycoprotein | Link | ||
| 91 | Association of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease | Link | ||
| 92 | A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 | Link | ||
| 93 | A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 | Link | ||
| 94 | Autopsy Findings and Causality Relationship between Death and COVID-19 | Link | ||
| 95 | 'Spikeopathy': COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine | Link | ||
| 96 | Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report | Link | ||
| 97 | HLA typing of patients who developed subacute thyroiditis and Graves' disease | Link | ||
| 98 | Autoimmune and inflammatory thyroid diseases following vaccination with | Link | ||
| 99 | A Case Report of Concurrent Graves' Disease and Subacute Thyroiditis Following | Link | ||
| 100 | Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case | Link | ||
| 101 | Comparison of Transient and Persistent Adverse Events After COVID-19 Vaccination: | Link | ||
| 102 | Analysis of hematologic adverse events reported to a national surveillance system | Link | ||
| 103 | Orbital inflammatory disease following mRNA SARS-CoV-2 vaccine. | Link | ||
| 104 | Orbital inflammation following COVID-19 vaccination: A case series and literature | Link | ||
| 105 | Increased risk of functional neurological disorders following SARS-CoV-2 | Link | ||
| 106 | Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a | Link | ||
| 107 | COVID-19 vaccination-related headache showed two different clusters in the | Link | ||
| 108 | SARS-CoV-2 vaccine-related neurological complications. | Link | ||
| 109 | Effect of COVID 19 pandemic on the neurology department hospitalization with | Link | ||
| 110 | X-linked Charcot-Marie-Tooth disease after SARS-CoV-2 vaccination mimicked | Link | ||
| 111 | Post-COVID-19 Vaccination CNS Magnetic Resonance Imaging Findings: A Systematic | Link | ||
| 112 | Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a | Link | ||
| 113 | Post-Vaccinal Encephalitis with Early Relapse after BNT162b2 (COMIRNATY) COVID-19 | Link | ||
| 114 | Seronegative acute encephalitis following COVID-19 vaccines: a case series of an | Link | ||
| 115 | Electroencephalographic findings post-COVID-19 vaccination: A systematic review | Link | ||
| 116 | The Neurological Implications of COVID-19: A Comprehensive Narrative Review. | Link | ||
| 117 | Neurological autoimmune diseases following vaccinations against severe acute | Link | ||
| 118 | Autoantibodies Targeting G-Protein-Coupled Receptors and RAS-Related Molecules in | Link | ||
| 119 | Severe acute respiratory syndrome coronavirus 2 vaccines and neurological diseases: Cause or coincidence? | Link | ||
| 120 | Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. | Link | ||
| 121 | Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2): A follow‐up study | Link | ||
| 122 | COVID‐19 Vaccine‐Associated Cerebral Venous Thrombosis in Germany | Link | ||
| 123 | Neurological autoimmune diseases following vaccinations against SARS‐CoV‐2: a case series | Link | ||
| 124 | First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland | Link | ||
| 125 | Guillain-Barre Syndrome following ChAdOx1-S/nCoV-19 Vaccine. | Link | ||
| 126 | Guillain-Barre Syndrome Variant Occurring after SARS-CoV-2 Vaccination. | Link | ||
| 127 | [Bell's Palsy Secondary to COVID-19 Vaccine Pfizer: Case report]. | Link | ||
| 128 | Bell's palsy and SARS-CoV-2 vaccines | Link | ||
| 129 | Left Bell's palsy following the first dose of mRNA-1273 SARS-CoV-2 vaccine: A | Link | ||
| 130 | Bell's Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis. | Link | ||
| 131 | Bell's palsy and SARS-CoV-2 vaccines—an unfolding story | Link | ||
| 132 | COVID-19 mRNA vaccination leading to CNS inflammation: a case series. | Link | ||
| 133 | A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders | Link | ||
| 134 | Acute central nervous system inflammation following COVID-19 vaccination: An | Link | ||
| 135 | Early-onset Cervical Myelitis after COVID-19 Vaccination. | Link | ||
| 136 | Initial clinical manifestation of multiple sclerosis after immunization with the | Link | ||
| 137 | CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and | Link | ||
| 138 | A comparative analysis on serious adverse events reported for COVID-19 vaccines | Link | ||
| 139 | Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report. | Link | ||
| 140 | Presentation of SLE after COVID vaccination in a pediatric patient. | Link | ||
| 141 | Latent Class Analysis Identifies Distinct Phenotypes of Systemic Lupus | Link | ||
| 142 | Disease exacerbation and COVID-19 following mRNA COVID-19 vaccination in | Link | ||
| 143 | New-onset Polymyalgia Rheumatica Following the Administration of the | Link | ||
| 144 | Systemic lupus erythematosus following COVID-19 vaccination. A systematic review | Link | ||
| 145 | Gross Hematuria after the COVID-19 mRNA Vaccination: Nationwide Multicenter | Link | ||
| 146 | Impact of COVID-19 vaccination on lower urinary tract (LUTS) in benign prostatic | Link | ||
| 147 | Exploring the adverse events of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, and | Link | ||
| 148 | Guillain-Barre syndrome after COVID-19 vaccination: A systematic review and | Link | ||
| 149 | Incidence of Guillain-Barre Syndrome After COVID-19 Vaccination in the Vaccine | Link | ||
| 150 | Guillain-Barre syndrome temporally associated with COVID-19 vaccines in Victoria, | Link | ||
| 151 | Side effects and flares risk after SARS-CoV-2 vaccination in patients with | Link | ||
| 152 | Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines. | Link | ||
| 153 | Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA | Link | ||
| 154 | Increased risk of myocarditis and pericarditis and reduced likelihood of severe | Link | ||
| 155 | SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million | Link | ||
| 156 | Fatal Myocarditis following COVID-19 mRNA Immunization: A Case Report and | Link | ||
| 157 | What would Hippocrates have sworn upon witnessing the COVID-19 mandates and | Link | ||
| 158 | Undesirable effects of COVID-19 vaccination on Saudi population: A descriptive | Link | ||
| 159 | Myocarditis With COVID-19 mRNA Vaccines. | Link | ||
| 160 | Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. | Link | ||
| 161 | Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan. | Link | ||
| 162 | IgA Nephropathy with Gross Hematuria Following COVID-19 mRNA Vaccination. | Link | ||
| 163 | Renal Complications Following COVID-19 Vaccination: A Narrative Literature | Link | ||
| 164 | Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) | Link | ||
| 165 | Bilateral Optic Neuritis and Hypophysitis With Diabetes Insipidus 1 Month After | Link | ||
| 166 | Thrombocytopenia after COVID-19 vaccination | Link | ||
| 167 | COVID-19 vaccination and the risk of autoimmune diseases: a Mendelian | Link | ||
| 168 | SARS-CoV-2 vaccines-induced thrombotic thrombocytopenia: should we consider | Link | ||
| 169 | Vaccine-Inducted Thrombotic Thrombocytopenia and Covid-19 Vaccines: Case Series. | Link | ||
| 170 | Pernicious Anemia Following COVID-19 Vaccination: A Report of Two Cases. | Link | ||
| 171 | Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome following | Link | ||
| 172 | Upper Limb Ischemia Due to Arterial Thrombosis after COVID-19 Vaccination. | Link | ||
| 173 | Sibling cases of gross hematuria and newly diagnosed IgA nephropathy following | Link | ||
| 174 | Abrupt worsening of occult IgA nephropathy after the first dose of SARS-CoV-2 | Link | ||
| 175 | Comparison of renal histopathology in three patients with gross hematuria after | Link | ||
| 176 | Cutaneous adverse events following COVID-19 vaccination: A case series of 30 | Link | ||
| 177 | A systematic review on mucocutaneous presentations after COVID-19 vaccination and | Link | ||
| 178 | Systematic lupus erythematous patients following COVID-19 vaccination: Its flares | Link | ||
| 179 | New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case | Link | ||
| 180 | Systemic lupus erythematosus with acute pancreatitis and vasculitic rash | Link | ||
| 181 | Clinical features of newly diagnosed systemic lupus erythematosus after | Link | ||
| 182 | New-onset acute psychosis as a manifestation of lupus cerebritis following | Link | ||
| 183 | New-Onset Systemic Lupus Erythematosus after mRNA SARS-CoV-2 Vaccination. | Link | ||
| 184 | New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: | Link | ||
| 185 | Investigating the association between SARS-CoV-2 infection, COVID-19 vaccination, | Link | ||
| 186 | Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected | Link | ||
| 187 | First manifestation of AQP4-IgG-positive neuromyelitis optica spectrum disorder | Link | ||
| 188 | The association between acute transverse myelitis and COVID-19 vaccination in | Link | ||
| 189 | Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event | Link | ||
| 190 | New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 | Link | ||
| 191 | Two adolescents with frequently relapsing nephrotic syndrome newly diagnosed | Link | ||
| 192 | Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 | Link | ||
| 193 | Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 | Link | ||
| 194 | ANCA-associated glomerulonephritis and lupus nephritis following COVID-19 | Link | ||
| 195 | Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine. | Link | ||
| 196 | First Report of Two Cases of Lofgren's Syndrome after SARS-CoV-2 | Link | ||
| 197 | Cubital Tunnel Syndrome Temporally after COVID-19 Vaccination. | Link | ||
| 198 | Minimal change disease following the Moderna COVID-19 vaccine: first case report. | Link | ||
| 199 | De novo podocytopathy following moderna COVID-19 vaccine: A case report and | Link | ||
| 200 | New Onset Biopsy-Proven Nephropathies after COVID Vaccination. | Link | ||
| 201 | Acute Interstitial Nephritis with Glomerular Capillary IgA Deposition Following | Link | ||
| 202 | Glomerular Disease in Temporal Association with SARS-CoV-2 Vaccination: A Series | Link | ||
| 203 | [A possible relationship between anti-SARS-CoV-2 vaccination and glomerular | Link | ||
| 204 | New insights into the mucosal immune pathogenesis of IgA nephropathy from the | Link | ||
| 205 | Assessing acute kidney injury risk after COVID vaccination and infection in a | Link | ||
| 206 | COVID-19 and Acute Kidney Injury Outcomes in Hospitalized Patients Following | Link | ||
| 207 | Secondary immunoglobulin A nephropathy with gross hematuria leading to rapidly | Link | ||
| 208 | New insights of antineutrophil cytoplasmic antibody-associated vasculitis from | Link | ||
| 209 | New-onset of rheumatic diseases following COVID-19 vaccination: the report of | Link | ||
| 210 | Disproportionality analysis of European safety reports on autoimmune and | Link | ||
| 211 | Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the | Link | ||
| 212 | Autoimmune inflammatory rheumatic diseases post-COVID-19 vaccination. | Link | ||
| 213 | Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with | Link | ||
| 214 | Capillary leak syndrome following COVID-19 vaccination: Data from the European | Link | ||
| 215 | Exacerbations of Idiopathic Systemic Capillary Leak Syndrome following BNT162b2 | Link | ||
| 216 | Erythema Multiforme Reactions Following Pfizer/BioNTech (Tozinameran) | Link | ||
| 217 | The systemic capillary leak syndrome following COVID-19 vaccine. | Link | ||
| 218 | Systemic capillary leak syndrome (SCLS) after receiving BNT162b2 mRNA COVID-19 | Link | ||
| 219 | Rapid Progression of COVID-19-Associated Fatal Capillary Leak Syndrome. | Link | ||
| 220 | Autoimmune disorders reported following COVID-19 vaccination: A | Link | ||
| 221 | mRNA COVID-19 vaccine safety among children and adolescents: a Canadian National | Link | ||
| 222 | Reports of Guillain-Barre Syndrome After COVID-19 Vaccination in the United | Link | ||
| 223 | Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age | Link | ||
| 224 | COVID-19 vaccination and cardiac dysfunction. | Link | ||
| 225 | Myocarditis or Pericarditis Following the COVID-19 Vaccination in Adolescents: A | Link | ||
| 226 | ERAP-1 and ERAP-2 Variants in Liver Injury After COVID-19 mRNA Vaccination: A US | Link | ||
| 227 | Autoimmune-Like Hepatitis Related to SARS-CoV-2 Vaccination: Towards a Clearer | Link | ||
| 228 | Outcomes and factors associated with relapse of vaccine-induced liver injury | Link | ||
| 229 | Acute myocarditis after COVID-19 vaccination. | Link | ||
| 230 | Development of myocarditis and pericarditis after COVID-19 vaccination in adult | Link | ||
| 231 | Increase in the number of new cases of ANCA-associated vasculitis in the COVID-19 | Link | ||
| 232 | ANCA-Positive Small-Vessel Vasculitis Following SARS-CoV-2 Vaccination-A | Link | ||
| 233 | Membranous Nephropathy following Full-Dose of Inactivated SARS-CoV-2 Virus | Link | ||
| 234 | New-Onset Acute Interstitial Nephritis Post-SARS-CoV-2 Infection and COVID-19 | Link | ||
| 235 | Two adolescent cases of acute tubulointerstitial nephritis after second dose of | Link | ||
| 236 | IgA nephropathy with glomerular capillary IgA deposition following SARS-CoV-2 | Link | ||
| 237 | New-onset minimal change disease following the Moderna COVID-19 vaccine. | Link | ||
| 238 | Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination. | Link | ||
| 239 | Minimal change disease following COVID-19 vaccination: A systematic review. | Link | ||
| 240 | Relapse of minimal change disease following the third mRNA COVID-19 vaccination: | Link | ||
| 241 | Do we miss rare adverse events induced by COVID-19 vaccination? | Link | ||
| 242 | COVID-19 Infection and Vaccination and Its Relation to Amyloidosis: What Do We | Link | ||
| 243 | Frequent Onsets of Cellulitis in Lower Limbs with Lymphedema Following COVID-19 | Link | ||
| 244 | Arm lymphedema after vascularized lymph node harvest following Covid-19 | Link | ||
| 245 | Ramsay-hunt-syndrome associated with unilateral parotitis following COVID-19 | Link | ||
| 246 | Herpesviruses reactivation following COVID-19 vaccination: a systematic review | Link | ||
| 247 | Unilateral lower extremity lymphedema followed by COVID-19 vaccination in | Link | ||
| 248 | Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination. | Link | ||
| 249 | Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: | Link | ||
| 250 | New-onset or flare-up of bullous pemphigoid associated with COVID-19 vaccines: a | Link | ||
| 251 | Worsening of bullous pemphigoid after a third booster dose of the Pfizer-BioNTech COVID-19 vaccine. | Link | ||
| 252 | Incidence of Herpes Zoster and Risk of Recurrence Following COVID-19 Vaccination. | Link | ||
| 253 | Reactivation of herpes zoster after BNT162b2 mRNA COVID-19 vaccination: A case report. | Link | ||
| 254 | Acute facial nerve palsy as a rare complication of SARS-CoV-2 vaccination: A case report and review of the literature. | Link | ||
| 255 | New-onset pemphigus foliaceus following COVID-19 vaccination: A case series and review of the literature. | Link | ||
| 256 | Cutaneous adverse effects of COVID-19 vaccines: A cross-sectional questionnaire-based study from India. | Link | ||
| 257 | Cutaneous adverse effects following COVID-19 vaccination: A prospective observational study from India. | Link | ||
| 258 | Cutaneous adverse reactions to COVID-19 vaccines: a prospective observational study from a tertiary care center in India. | Link | ||
| 259 | Acute disseminated encephalomyelitis following COVID-19 vaccination: A report of two cases. | Link | ||
| 260 | Post-COVID-19 vaccine autoimmune encephalitis: Literature review and case report of post-vaccine autoimmune encephalitis with long-term follow-up. | Link | ||
| 261 | Guillain-Barré Syndrome following COVID-19 vaccination: A systematic review of case reports and case series. | Link | ||
| 262 | Central nervous system demyelination following COVID-19 mRNA vaccination: A case series and review of the literature. | Link | ||
| 263 | New onset multiple sclerosis after mRNA SARS-CoV-2 vaccination: A case series. | Link | ||
| 264 | COVID-19 vaccine-associated myelitis: a brief review and case report. | Link | ||
| 265 | Multifocal motor neuropathy after COVID-19 vaccination: A case report and literature review. | Link | ||
| 266 | Acute transverse myelitis following mRNA COVID-19 vaccination: A case report and review of literature. | Link | ||
| 267 | Optic neuritis and myelitis associated with COVID-19 mRNA vaccine: A case report and literature review. | Link | ||
| 268 | Optic neuritis following COVID-19 mRNA vaccination: Case report and review of literature. | Link | ||
| 269 | Acute disseminated encephalomyelitis following AstraZeneca COVID-19 vaccination: A case report and literature review. | Link | ||
| 270 | Longitudinal extensive transverse myelitis following COVID-19 mRNA vaccine: A case report and literature review. | Link | ||
| 271 | Neurological complications of COVID-19 vaccines: A systematic review and meta-analysis of case reports and series. | Link | ||
| 272 | Vaccine-associated autoimmune encephalitis: A review of recent case reports and pathophysiological mechanisms. | Link | ||
| 273 | Autoimmune encephalitis following COVID-19 vaccination: A case report and review of the literature. | Link | ||
| 274 | Neuroimmunologic complications of COVID-19 and COVID-19 vaccines: Pathogenesis and therapeutic implications. | Link | ||
| 275 | Acute demyelinating encephalomyelitis following COVID-19 mRNA vaccination: A systematic review of case reports. | Link | ||
| 276 | COVID-19 vaccine-associated central nervous system demyelination: a review of 10 cases. | Link | ||
| 277 | Vaccine-induced encephalitis following mRNA COVID-19 vaccines: Systematic review and analysis. | Link | ||
| 278 | Neurological immune-related adverse events associated with COVID-19 vaccination: A case series and review of the literature. | Link | ||
| 279 | COVID-19 vaccine-induced encephalopathy: Clinical characteristics and review of published cases. | Link | ||
| 280 | Long COVID and autoimmune encephalitis: possible overlaps and diagnostic challenges. | Link | ||
| 281 | Autoimmune Encephalitis After COVID-19 Vaccination: Case Report and Literature Review. | Link | ||
| 282 | Acute transverse myelitis following SARS-CoV-2 vaccination: A case series and review of the literature. | Link | ||
| 283 | Neurological complications after COVID-19 vaccines: systematic review and meta-analysis of case reports. | Link | ||
| 284 | Post-vaccine autoimmune demyelination: Overview and therapeutic approaches. | Link | ||
| 285 | Neurological manifestations following COVID-19 vaccines: A global safety surveillance analysis. | Link | ||
| 286 | Neurological side effects of COVID-19 vaccines: A systematic review and meta-analysis. | Link | ||
| 287 | Vaccine-associated neurological adverse events: Insights into pathogenesis and public health perspectives. | Link | ||
| 288 | Autoimmune neurology and COVID-19 vaccines: Emerging correlations and clinical implications. | Link | ||
| 289 | Autoimmune Neurological Disorders Following COVID-19 Vaccination: Pathophysiology and Emerging Evidence. | Link | ||
| 290 | Neurological Adverse Events Reported Post-COVID-19 Vaccination: A Global Perspective. | Link | ||
| 291 | Assessing Risk of Neurological Adverse Reactions in mRNA COVID-19 Vaccines: Case Series and Literature Review. | Link | ||
| 292 | Acute Neuroimmune Events Post COVID-19 Vaccination: Systematic Review and Meta-Synthesis. | Link | ||
| 293 | Case reports of autoimmune encephalitis and transverse myelitis following COVID-19 immunization: A literature review. | Link | ||
| 294 | Post-vaccination Central Nervous System Inflammation: A Rare but Serious Complication. | Link | ||
| 295 | Autoimmune Encephalitis and Demyelination Following SARS-CoV-2 Vaccination: What We Know So Far. | Link | ||
| 296 | Long-term Neurological Sequelae Post COVID-19 Vaccination: A Narrative Review. | Link | ||
| 297 | Immune-mediated neurological events after SARS-CoV-2 mRNA vaccination: an overview of reported case studies. | Link | ||
| 298 | Guillain-Barre Syndrome Following mRNA COVID-19 Vaccines: A Comprehensive Review. | Link | ||
| 299 | Pathological Evidence of Vaccine-Induced Immune Thrombotic Thrombocytopenia. | Link | ||
| 300 | Cerebral venous thrombosis after COVID-19 vaccination: A case series and systematic review. | Link | ||
| 301 | COVID-19 vaccination-related cerebral venous sinus thrombosis: A clinical case series and literature overview. | Link | ||
| 302 | COVID-19 vaccination and cerebral venous thrombosis: A single-center case series. | Link | ||
| 303 | Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: Report from a national surveillance system. | Link | ||
| 304 | Intracerebral hemorrhage post-COVID-19 vaccination: Case report and literature review. | Link | ||
| 305 | Cerebral venous thrombosis associated with mRNA vaccines: A pharmacovigilance analysis. | Link | ||
| 306 | Post-vaccine autoimmune thrombocytopenia: Case report and literature review. | Link | ||
| 307 | Immune thrombocytopenic purpura after COVID-19 vaccination: A systematic review of case reports. | Link | ||
| 308 | Vaccination-induced thrombotic events: Mechanistic insights and clinical consequences. | Link | ||
| 309 | COVID-19 vaccine-induced immune thrombotic thrombocytopenia: Clinical features and management approach. | Link | ||
| 310 | Thrombotic complications associated with COVID-19 vaccines: An analysis of current evidence. | Link | ||
| 311 | Myocarditis following mRNA COVID-19 vaccination: A systematic review of published case reports. | Link | ||
| 312 | Myocarditis and pericarditis following mRNA COVID-19 vaccination: Clinical presentation and management. | Link | ||
| 313 | Incidence of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults: A national cohort study. | Link | ||
| 314 | Risk of myocarditis after COVID-19 mRNA vaccination: A systematic review and meta-analysis. | Link | ||
| 315 | Cardiovascular adverse events following COVID-19 vaccination: A systematic review. | Link | ||
| 316 | Acute myocarditis after mRNA COVID-19 vaccination: A global review of reported cases. | Link | ||
| 317 | Vaccine-associated myocarditis: Incidence, pathophysiology, and management strategies. | Link | ||
| 318 | Clinical spectrum of myocarditis after COVID-19 vaccination: A multicenter case series. | Link | ||
| 319 | Myocarditis following COVID-19 booster vaccination: A case series and literature review. | Link | ||
| 320 | Post-vaccination myocarditis in adolescents: A detailed clinical and echocardiographic study. | Link | ||
| 321 | Myocardial inflammation following SARS-CoV-2 mRNA vaccination: A case series. | Link | ||
| 322 | COVID-19 vaccine-associated myocarditis and pericarditis in adolescents: A multicenter case series. | Link | ||
| 323 | Risk of myocarditis from COVID-19 vaccination in young males: National database analysis. | Link | ||
| 324 | Post-COVID-19 vaccine myocarditis: Systematic review and proposed mechanisms. | Link | ||
| 325 | Myocarditis and COVID-19 vaccination: Risk analysis and comparison with infection-induced myocarditis. | Link | ||
| 326 | Acute pericarditis post COVID-19 vaccination: A case series. | Link | ||
| 327 | Pericarditis following COVID-19 mRNA vaccine: Clinical and echocardiographic findings. | Link | ||
| 328 | Pericardial complications associated with COVID-19 mRNA vaccination: Systematic case review. | Link | ||
| 329 | Post-vaccination pericarditis: Analysis of VAERS and case literature. | Link | ||
| 330 | Pericarditis in adolescents following COVID-19 vaccine: A systematic literature review. | Link | ||
| 331 | Cardiac side effects of COVID-19 vaccines in pediatric populations: A review of reported cases. | Link | ||
| 332 | Comparison of myocarditis and pericarditis post-mRNA vaccines: Systematic case analysis. | Link | ||
| 333 | Vaccine-induced myocardial injury in young adults: Clinical features and outcome. | Link | ||
| 334 | Post-COVID-19 vaccine myocarditis: Incidence and pathophysiology review. | Link | ||
| 335 | Case series of myocarditis following COVID-19 mRNA vaccination in young males. | Link | ||
| 336 | Clinical characteristics of vaccine-induced myocarditis: Lessons from COVID-19 vaccination. | Link | ||
| 337 | COVID-19 mRNA vaccines and cardiac inflammation: A comprehensive review. | Link | ||
| 338 | Myocarditis incidence in adolescent males after COVID-19 mRNA vaccination: Review of public data. | Link | ||
| 339 | Comparison of vaccine-associated myocarditis with viral myocarditis: Meta-analysis. | Link | ||
| 340 | Myocarditis and pericarditis reports post-COVID-19 vaccination: A national surveillance study. | Link | ||
| 341 | Systemic and cardiac inflammatory response post-COVID-19 mRNA vaccination: Case series. | Link | ||
| 342 | Post-mRNA vaccine myocarditis in patients under 25: Risk and benefit analysis. | Link | ||
| 343 | COVID-19 vaccination and cardiovascular inflammation: Mechanisms and case examples. | Link | ||
| 344 | Cardiac adverse events in adolescents after COVID-19 vaccination: An evidence-based summary. | Link | ||
| 345 | Clinical and imaging features of post-vaccination myocarditis in young adults. | Link | ||
| 346 | Immunological mechanisms underlying myocarditis after mRNA vaccination. | Link | ||
| 347 | mRNA vaccine-associated myocarditis: What we know, what we suspect, and what remains to be clarified. | Link | ||
| 348 | Case reports of myocarditis after mRNA vaccines: A review of the evidence. | Link | ||
| 349 | Cardiovascular safety signals from COVID-19 vaccines: Review of spontaneous reports. | Link | ||
| 350 | mRNA vaccine-induced pericarditis: Case reports and mechanistic hypotheses. | Link | ||
| 351 | Post-COVID-19 vaccine myopericarditis: A case series and discussion of clinical approach. | Link | ||
| 352 | Post-vaccine cardiac events: Comparative analysis of risk across mRNA platforms. | Link | ||
| 353 | Systematic review of pericardial complications after mRNA COVID-19 vaccination. | Link | ||
| 354 | COVID-19 vaccination and myocarditis: Case reports and literature synthesis. | Link | ||
| 355 | Myopericarditis following COVID-19 vaccine: Clinical presentation and outcomes. | Link | ||
| 356 | Risk of cardiac inflammation after COVID-19 mRNA vaccination: A national VAERS analysis. | Link | ||
| 357 | Pericarditis and myocarditis after COVID-19 vaccination: Mechanistic and clinical perspectives. | Link | ||
| 358 | COVID-19 mRNA vaccine–associated myopericarditis: Systematic case evaluation. | Link | ||
| 359 | Post-mRNA vaccination myocarditis in adolescents: VAERS and clinical data analysis. | Link | ||
| 360 | Pericarditis after COVID-19 mRNA vaccine: Report of five cases and literature review. | Link | ||
| 361 | Myocarditis following BNT162b2 vaccine in adolescents: A clinical and imaging study. | Link | ||
| 362 | Vaccine-associated pericardial disease: A national pharmacovigilance assessment. | Link | ||
| 363 | Longitudinal follow-up of adolescents with vaccine-induced myocarditis. | Link | ||
| 364 | Myocardial injury post-COVID-19 mRNA vaccine: Incidence and clinical characteristics. | Link | ||
| 365 | Myocarditis in children post COVID-19 vaccination: A prospective cohort study. | Link | ||
| 366 | Myocarditis after mRNA-1273 vaccine in adolescents: VAERS review and case examples. | Link | ||
| 367 | Reversible myocarditis in young males following COVID-19 mRNA vaccination. | Link | ||
| 368 | Post-vaccination pericarditis: Short-term outcomes and management. | Link | ||
| 369 | Cardiovascular side effects of COVID-19 vaccines: Review of reported myocarditis and pericarditis cases. | Link | ||
| 370 | Vaccine-induced myocarditis in adolescents: Report from a national registry. | Link | ||
| 371 | Long-term cardiac outcomes following vaccine-induced myocarditis in teenagers. | Link | ||
| 372 | Pericardial inflammation after COVID-19 vaccination: A case series. | Link | ||
| 373 | Myocarditis surveillance post COVID-19 vaccine rollout: National public health data. | Link | ||
| 374 | COVID-19 vaccine–associated myocarditis in children: Literature synthesis and case illustrations. | Link | ||
| 375 | Myocarditis after mRNA vaccination: Case reports and potential mechanisms. | Link | ||
| 376 | COVID-19 vaccine safety in adolescents: Focus on cardiac adverse events. | Link | ||
| 377 | Case report: Pericarditis in a young male post COVID-19 mRNA vaccine. | Link | ||
| 378 | Perimyocarditis after mRNA COVID-19 vaccine in a 14-year-old boy: Case report and discussion. | Link | ||
| 379 | Adverse cardiac effects of COVID-19 vaccines: Systematic literature review. | Link | ||
| 380 | Post-vaccine myocarditis and pericarditis: Incidence and outcomes in young adults. | Link | ||
| 381 | Vaccine-related myocarditis: Pathogenesis and clinical management. | Link | ||
| 382 | Myocarditis cases in adolescents post BNT162b2 vaccine: Observations and follow-up. | Link | ||
| 383 | Acute myocarditis in a 13-year-old post COVID-19 vaccine: Case report. | Link | ||
| 384 | Risk of cardiac events post mRNA COVID-19 vaccine: An updated systematic review. | Link | ||
| 385 | Post-vaccine myocarditis and arrhythmia in a pediatric population. | Link | ||
| 386 | COVID-19 vaccination-related cardiac complications: A review of case reports. | Link | ||
| 387 | Myocarditis after booster dose of mRNA vaccine in adolescent males: Case series. | Link | ||
| 388 | COVID-19 vaccine–induced myocarditis in adolescents: Short-term follow-up data. | Link | ||
| 389 | Cardiac inflammation after COVID-19 vaccination: Incidence by age and dose. | Link | ||
| 390 | Clinical features of adolescent myocarditis after mRNA COVID-19 vaccination: Case review. | Link | ||
| 391 | Myocarditis linked to COVID-19 vaccines: A pediatric case series. | Link | ||
| 392 | Myocarditis in pediatric patients after COVID-19 vaccination: Review of public case data. | Link | ||
| 393 | Pericarditis in young patients after mRNA vaccine: A case-based update. | Link | ||
| 394 | Adverse cardiac events post COVID-19 booster: Systematic case compilation. | Link | ||
| 395 | Post-mRNA vaccination myocarditis: Retrospective review from multiple centers. | Link | ||
| 396 | Myocarditis in adolescents after mRNA COVID-19 vaccine: Case studies with follow-up. | Link | ||
| 397 | Cardiac complications post COVID-19 vaccine: Case report and discussion. | Link | ||
| 398 | Pericarditis after COVID-19 booster: Clinical profile and outcomes. | Link | ||
| 399 | Bilateral ischemic optic neuropathy from giant cell arteritis after vaccination. | Link | ||
| 400 | Optic neuropathy after mRNA COVID-19 vaccine: Case report. | Link | ||
| 401 | Acute visual loss following COVID-19 vaccination: A case report of bilateral optic neuritis. | Link | ||
| 402 | Optic neuritis post COVID-19 mRNA vaccine: Case report and review. | Link | ||
| 403 | Isolated optic neuritis following SARS-CoV-2 vaccination. | Link | ||
| 404 | Case series of optic neuritis following COVID-19 mRNA vaccination. | Link | ||
| 405 | Autoimmune optic neuritis after BNT162b2 mRNA COVID-19 vaccine. | Link | ||
| 406 | Optic neuritis in adolescent post mRNA COVID-19 vaccine: Case report. | Link | ||
| 407 | Bilateral optic neuritis after BNT162b2 vaccine: A case presentation. | Link | ||
| 408 | Optic neuropathy post COVID-19 vaccination: Evidence from case reports. | Link | ||
| 409 | Neuro-ophthalmologic complications of COVID-19 vaccination: Case series analysis. | Link | ||
| 410 | Review of optic nerve disorders following COVID-19 vaccination. | Link | ||
| 411 | Longitudinal optic neuritis in mRNA-vaccinated adolescents: Case series. | Link | ||
| 412 | Inflammatory optic neuropathy post COVID-19 vaccine in a teenage male. | Link | ||
| 413 | Reversible optic neuritis after mRNA COVID-19 vaccine in pediatric patient. | Link | ||
| 414 | SARS-CoV-2 mRNA Vaccination and Bell’s Palsy: Systematic review and case evaluation. | Link | ||
| 415 | Bell’s palsy following COVID-19 mRNA vaccination in adolescents: Case series and mechanism discussion. | Link | ||
| 416 | Facial palsy post COVID-19 vaccination: A pediatric case report. | Link | ||
| 417 | Bell’s palsy in children after mRNA COVID-19 vaccine: National database assessment. | Link | ||
| 418 | Bell’s palsy with COVID-19 vaccine: A case report and literature review. | Link | ||
| 419 | COVID-19 vaccine-related facial nerve palsy in adolescents: Case reports. | Link | ||
| 420 | Temporal correlation between BNT162b2 vaccine and Bell’s palsy onset. | Link | ||
| 421 | Post-COVID vaccine Bell’s palsy: Clinical evaluation in adolescent cohort. | Link | ||
| 422 | Rapid-onset Bell’s palsy in child following COVID-19 vaccine. | Link | ||
| 423 | Bilateral Bell’s palsy following mRNA vaccine: Rare pediatric case report. | Link | ||
| 424 | Facial nerve palsy in pediatric vaccine recipients: Surveillance data analysis. | Link | ||
| 425 | Long-term outcomes in adolescents with Bell’s palsy post-COVID-19 vaccine. | Link | ||
| 426 | Bell’s palsy after COVID-19 mRNA vaccination: Time to onset and recovery in youth. | Link | ||
| 427 | Facial nerve neuropathy post mRNA vaccination: A pediatric observation. | Link | ||
| 428 | Unilateral Bell’s palsy after Pfizer vaccine in a 15-year-old boy: Case report. | Link | ||
| 429 | Pediatric Bell’s palsy spike post COVID-19 vaccination: Database trend analysis. | Link | ||
| 430 | Acute unilateral facial nerve palsy in teenager post COVID vaccine: A rare case. | Link | ||
| 431 | Bell’s palsy incidence post COVID-19 vaccine in adolescents: Cross-sectional study. | Link | ||
| 432 | Peripheral facial nerve palsy in children post COVID-19 vaccine: Evaluation of cases. | Link | ||
| 433 | Facial paralysis after second dose of BNT162b2 mRNA vaccine: Pediatric case review. | Link | ||
| 434 | Bell’s palsy in a 12-year-old post COVID-19 vaccine: Diagnosis and management. | Link | ||
| 435 | CDC protocol for COVID-19 vaccine breakthrough case investigations. | Link | ||
| 436 | COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia | Link | ||
| 437 | Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine | Link | ||
| 438 | Vaccine administration and the development of immune thrombocytopenic purpura in children | Link | ||
| 439 | Spectrum of neurological complications following COVID-19 vaccination | Link | ||
| 440 | Two Cases of Post-Moderna COVID-19 Vaccine Encephalopathy Associated With Nonconvulsive Status Epilepticus | Link | ||
| 441 | New-onset refractory status epilepticus due to autoimmune encephalitis after vaccination against SARS-CoV-2: First case report | Link | ||
| 442 | Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination | Link | ||
| 443 | Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine | Link | ||
| 444 | Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients | Link | ||
| 445 | Encephalitis following COVID-19 Vaccination: A Systematic Review | Link | ||
| 446 | Aseptic Meningitis Following Second Dose of an mRNA Coronavirus Disease 2019 Vaccine in a Healthy Male: Case Report and Literature Review | Link | ||
| 447 | Aseptic Meningitis after BNT-162b2 COVID-19 Vaccination: Case Report and Literature Review | Link | ||
| 448 | Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19 | Link | ||
| 449 | Post-COVID-19 Vaccination Meningitis and Meningoencephalitis: A Systematic Review of Case Series and Case Reports | Link | ||
| 450 | Postural orthostatic tachycardia syndrome after COVID-19 vaccination: A systematic review | Link | ||
| 451 | Worse Than the Disease? Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID-19 | Link | ||
| 452 | Myocarditis, Coagulopathy, and Small Fibre, Sensory, and Multiple Cranial Nerve Neuropathy Complicating BNT162b2 Vaccination: A Case Report | Link |